The Insurance Regulatory and Development Authority of India (IRDAI) has revised guidelines governing liaison offices (LOs) of overseas insurers, tightening eligibility norms, compliance requirements, and closure procedures in a move that signals closer regulatory scrutiny of foreign market engagement.
The regulator issued revised guidelines on the establishment and closure of liaison offices by insurance companies registered outside India, superseding its 2022 framework with immediate effect.
Extension window widens to 3+3 years
The most significant change is the extension framework. The revised 2026 framework now allows an extension for another three years, effectively creating a 3+3 model. Under the 2022 guidelines, overseas insurers were granted an initial three-year approval, with the option to seek only a one-year extension.
In addition, IRDAI has introduced a new pathway permitting continuation beyond six years in exceptional cases. Where an LO demonstrates strategic importance — including bilateral trade significance, facilitation of foreign direct investment inflows, technology transfer or broader market development — the regulator may grant further three-year extensions on a case-by-case basis, subject to periodic review.
Explicit net worth relaxation provision
While the baseline eligibility threshold remains intact, the 2026 guidelines now explicitly empower IRDAI to relax the net worth requirement in exceptional cases. Rules still require an insurer to have a profit-making track record for the preceding three financial years and a minimum net worth of US$65m,
Furthermore, the discretion applies particularly to foreign state-owned enterprises, reinsurers with strong credit ratings or specialised insurers, taking into account bilateral trade significance and scope for market development.
Clearer structural prohibition on dual presence
The updated rules also strengthen structural clarity regarding market entry pathways.
Under the new guidelines, an overseas insurer cannot simultaneously maintain a liaison office in India and act as a joint venture partner in an Indian insurance company. If the insurer intends to open a foreign reinsurance branch, joint venture or subsidiary for insurance operations, the existing LO must be closed at the time regulatory approval for the new structure is granted.
While the 2022 framework had addressed overlapping structures through transitional closure provisions, the 2026 version frames the restriction as a standing prohibition.
Higher fee
The revised framework also increases the non-refundable extension processing fee to US$5,000, up from US$2,500 under the 2022 guidelines. The initial application fee remains unchanged at US$6,000.
Compliance architecture largely unchanged
Beyond tenure and structural revisions, the core compliance architecture remains broadly consistent with the 2022 framework.
Liaison offices remain strictly non-commercial entities permitted only to represent the overseas insurer, conduct market research, and act as communication channels. They must operate solely from inward foreign remittances and are barred from underwriting, solicitation, lending, deposit-taking or property acquisition beyond limited lease arrangements.
Annual audited financial statements, an Annual Activity Certificate, and mandatory disclosures of any regulatory action in the home jurisdiction within 15 days continue to apply. IRDAI retains inspection and withdrawal powers in cases of non-compliance.
